Clinical Trials Logo

Clinical Trial Summary

To compare the effect of treatment with teriparatide with that of salmon calcitonin in postmenopausal women with osteoporosis.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00543023
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 3
Start date June 2003
Completion date August 2004

See also
  Status Clinical Trial Phase
Completed NCT00532207 - Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis Phase 3
Completed NCT00018447 - Combination Osteogenic Therapy in Established Osteoporosis Phase 2
Completed NCT00532246 - Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo Phase 4
Completed NCT00927186 - Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women Phase 4
Completed NCT00543218 - PTH Comparison in Post Menopausal Women Phase 3
Completed NCT00532545 - Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis Phase 4
Completed NCT00532428 - Long Term Effects of Raloxifene Treatment on Bone Quality Phase 4